Introduction: Breast carcinoma is the most prevalent malignancy and the second leading cause of cancer death in women, while multiple primaries are conditions where there is more than one synchronous or metachronous cancer in one individual. Double primary between breast carcinom...
Open access
Research Article10.9734/jcti/2024/v14i4264
King Williams, Emmanson Godswill, Chiamaka Mercy, Uchechukwu Gift Chinenye, Ochai Onyiba Blessing, Imonikhu Francis, Ajifolawe Oladotun, Franklin Uche & Williams Williams·Journal of Cancer and Tumor International·2024
Gynecological cancers, notably breast and ovarian cancers, exhibit significant heterogeneity, complicating treatment strategies and impacting patient outcomes. Traditional cancer models often fail to capture the complexity and diversity of these tumors. Induced pluripotent stem c...
Open access
Research Article10.9734/jcti/2024/v14i4262
Background: Breast cancer continues to be a substantial worldwide health issue, impacting millions of individuals and families annually. Gaining insight into individuals' perception and reaction to the risk of breast cancer is crucial for advancing early detection and successful...
Open access
Research Article10.9734/jcti/2024/v14i4263
This systematic review explores the role of artificial intelligence (AI) and machine learning (ML) technologies in the diagnosis and treatment of thyroid cancers (TC), focusing on enhancing precision, risk assessment, and tailored care. By analyzing ten studies, the review highli...
Open access
Research Article10.9734/jcti/2024/v14i3261
Naeema Salatia Hoque, Md.Sakhawat Hossain, Md. Ashikur Rahaman, Rifaia Sultana Chowdhury, Md. Ashraful Alam, Md. Imran Hossain & Rahima Tanbin Tama·Journal of Cancer and Tumor International·2024
One of the most dreaded diseases is cancer whose biological process has long been the focus of scientific inquiry. Changes to normal cellular pathways that result in uncontrolled cell growth and proliferation are widely accepted as the primary cause of cancer. It is known as canc...
Open access
Research Article10.9734/jcti/2024/v14i3260
The development of antibody-drug conjugates (ADCs) has significantly impacted cancer therapy, progressing from foundational discoveries in the late 19th century to contemporary clinical applications. With the approval of the first ADC in 2000 and subsequent advancements, includin...
Open access
Research Article10.9734/jcti/2024/v14i3259
Introduction: Breast cancer remains a major health problem and a top priority for biomedical research. The incidence of this aggressive disease is around 1,700,000 new cases each year; This figure shows the low level of efforts to prevent this disease. About 12% of breast cancer...
Open access
Research Article10.9734/jcti/2024/v14i3257
A brain tumour may start somewhere else and go to the brain or originate in the brain cells (as demonstrated). Signs and symptoms including headaches, nausea, and balance issues are brought on by the tumour's growth, which puts pressure on adjacent brain tissue and alters its fun...
Open access
Research Article10.9734/jcti/2024/v14i3258
Background and Objectives: Lymph node involvement is uncommon in early-stage cervical cancer (7-20%), with low volume nodal disease (micrometastasis and isolated tumour cells) representing a further small subset (2-23%) of this small population. Fewer data are available on the i...
Open access
Research Article10.9734/jcti/2024/v14i3256
Aims: Port site recurrence is a rare complication of laparoscopic or robotic surgery for gynaecological cancer. The exact mechanism is not well understood and there are few cases detailing this phenomenon specifically after robotic assisted surgery for gynaecological cancer. The...
Open access
Research Article10.9734/jcti/2024/v14i3255